Convertible Financing 101 for the Entrepreneur
Ophthalmic Product Development Insights
Right Between Your Eyes
A look at ocular/nasal interactions and how they can affect our
pharmaceutical therapies.
The Hottest Topics From ARVO 2016
A look at the latest research from multiple corners of ophthalmology, from gene therapy to dry eye.
Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial for DEXTENZA™ for the Treatment of Allergic Conjunctivitis
DEXTENZA successfully met primary endpoint for treatment of ocular itching associated with allergic conjunctivitis
ARVO 2015 meeting finds connections in innovative drug delivery, therapies
Cutting-edge progress also continues in retina, cornea, dry eye, gene-based science
Delivering a Rocky Mountain ARVO
A rundown of the most interesting research in a variety of subspecialties presented at this year’s ARVO meeting.
The Secrets of Ocular Microbiomes
The placid ocular surface is actually teeming with life that might
hold the secret to treating ophthalmic disease.
Advances in pharmacotherapy for allergic conjunctivitis
Allergic conjunctivitis is a common and potentially debilitating condition affecting
the conjunctiva, eyelids and cornea, and it is often associated with nonocular symptoms
and signs of rhinitis or sinusitis.
Quarterly Ora Newsletter - May 1, 2015
Customer Success Stories: Celebrating Your Big Wins in 2014-2015
Biocube allergen chamber study to start for new therapeutic for rhinitis indication
Clinical trial for the treatment of allergic rhinitis for 3E Therapeutics Corporation